Solving your challenges with exceptional imaging performance

GE Healthcare provides clinicians with innovative imaging solutions and pharmaceutical diagnostic imaging agents, spanning from oncology solutions to magnetic resonance imaging to surgical imaging and more.

Our intelligent products and solutions help achieve optimized exam workflows, improved clinical outcomes and efficient imaging operations.

Discover a bold new world with SIGNA™ MR

Learn about advances in imaging and about GE's latest innovations from key opinion leaders in MR.

IMAGING SPOTLIGHTS

Open up the MR bore and so much more

Are you seeking a replacement for your legacy 1.5T and 3.0T MR system? SIGNA™ Evo¹ is a transformational upgrade which opens up the bore from 60 cm to 70 cm. Breathe new life into legacy 1.5T and 3.0T MR systems with SIGNA Evo – the world's first and only narrow-to-wide bore transformation.

Extremity imaging performed easily

For orthopedic imaging of extremities, the OEC MiniView enables surgeons to single-handedly capture clear, fast, and convenient images in surgical suites or clinics for greater efficiency every day.

See the AMX™ Navigate in "one of the coldest places on earth"

With a new level of effortless workflow, clinical excellence, and rugged reliability, the AMX Navigate advanced mobile X-ray system is engineered to deliver consistent, reliable results whenever and wherever you need it. See it in action in Kiruna, Sweden.

GE Healthcare and Elekta collaborate to expand access to precision radiation therapy solutions

GE Healthcare and Elekta announced that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy.

177Lu-PSMA approval for treatment of metastatic castrate-resistant prostate cancer

177Lu PSMA-617 is the latest radioligand therapy to be approved by the FDA.² In the field of theranostics, it brings the potential to combine therapy and diagnostic imaging for the personalization of prostate cancer treatment.

PET/CT, SPECT/CT and dosimetry can work together to assist in treatment personalization.

GE Healthcare offers molecular imaging solutions for discovery, diagnosis, and treatment planning and monitoring to drive personalized medicine.

NEWS AND INSIGHTS

Differentiating clinical practice for breast care with a new formula for success

Providing continuity in patient care is a priority for success of the One-Stop Clinic. It is differentiating how care providers can improve women's health. Most importantly, it's positively impacting clinical outcomes, but it's also changing operational efficiencies and the overall patient experience.

Revolutionizing MRI with bone imaging

Magnetic Resonance Imaging (MRI)-based qualitative imaging of cortical bone has drawn great interest among MSK radiologists and orthopedic and pediatric specialists. Expanding MRI capabilities to allow cortical bone visualization offers clinicians the opportunity to assess both tissue types simultaneously, which can help when planning treatments or special surgeries.

A new edition of SIGNA™ Pulse of MR

Our highly anticipated Spring issue of SIGNA Pulse of MR features a special spotlight section on the clinical impact of deep-learning reconstruction algorithms on image quality and productivity. This dedicated section contains articles that demonstrate the outstanding image quality and potential for reducing acquisition times in MR enterography, abdominal imaging, and multi-parametric prostate exams.

UPCOMING EVENTS AND WEBINARS

Society of Nuclear Medicine and Molecular Imaging

June 11 – 14, 2022
Vancouver, BC, Canada

GE is excited to attend the 1st in-person SNMMI conference in 3 years! We hope to see you there at Booth 1425 in the Vancouver Convention Center.

We continue to believe the future of molecular imaging is personal, and that every step of the care you provide is an opportunity to make personalized decisions for your patients.

At SNMMI, we'll be showcasing innovations across our entire portfolio so that you have a Total MI solution that connects every step in molecular medicine.

Society of Interventional Radiology

June 11 – 16, 2022
Boston, MA

What if you could perform more complex procedures effectively with a multi-modality fusion? Come visit GE Healthcare in booth #326 for a personalized tour to learn how we're turning patient pathways into super highways!

Webinar - Realizing Photon Counting CT's Full Potential

June 22, 2022 at 12:30PM CST

Join us for a one-hour RSNA webinar and panel discussion to discover the exciting possibilities of Photon Counting CT. The discussion will highlight the evolution of advanced computed tomography state-of-the-art technology and what could be achieved by fully enabling photon counting CT. Sponsored by GE Healthcare, this free webinar will feature a panel of guest speakers, followed by a live Q&A session.

¹SIGNA™ Artist Evo is not yet CE marked. Not commercially available in all markets.
²FDA: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pluvicto-metastatic-castration-resistant-prostate-cancer

© 2022 General Electric Company

GE, the GE Monogram, AMX and SIGNA are trademarks of GE.

Not all products or features are available in all geographies. Check with your local GE Healthcare representative for availability in your country.

JB20340XX